Paloma Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Paloma Partners’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,251	Closed	-$492K	–	2021
2018 Q2	$492K	Buy	+4,251	New	+$467K	0.01%	1044
2018 Q1	–	Sell	-31,473	Closed	-$3.3M	–	2325
2017 Q4	$3.3M	Buy	+31,473	New	+$3.46M	0.04%	448
2017 Q2	–	Sell	-2,982	Closed	-$348K	–	2496
2017 Q1	$348K	Buy	+2,982	New	+$330K	﹤0.01%	1696
2016 Q3	–	Sell	-3,558	Closed	-$518K	–	2193
2016 Q2	$518K	Buy	+3,558	New	+$505K	0.01%	1525
2016 Q1	–	Sell	-3,224	Closed	-$498K	–	2121
2015 Q4	$498K	Buy	+3,224	New	+$471K	0.01%	1035

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Paloma Partners's TARO Position: Q3 2018 in Review

Paloma Partners sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2018, closing a stake of 4,251 shares — an estimated $492K sold.

Paloma Partners first reported a position in TARO in Q4 2015 and held it in 5 quarters. The position peaked at $3.3M in Q4 2017. 114 funds tracked by Wall St. Rank hold TARO as of Q3 2018.

Paloma Partners reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2018 after selling out during the quarter.
Paloma Partners sold 4,251 Taro Pharmaceutical Industries Ltd. shares in Q3 2018, an estimated $492K.
Paloma Partners first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 5 quarters.
Paloma Partners's Taro Pharmaceutical Industries Ltd. position peaked at $3.3M in Q4 2017.
114 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2018.

Based on Paloma Partners's 13F filing for Q3 2018, filed 14 Nov 2018.